Overview

Chromium and Insulin Action

Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
The effect of Chromium to improve glucose levels in diabetes is controversial. The hypothesis of the study was to evaluate the effect of supplementing the diet of individuals with Type 2 diabetes with chromium picolinate and assessing the effect on blood glucose levels and insulin sensitivity
Phase:
Phase 4
Details
Lead Sponsor:
Pennington Biomedical Research Center
Treatments:
Chromium
Picolinic acid